FDA Warning Letters to GLP-1 Peptide Vendors (Sept 2025) In September 2025, the FDA issued more than 50 warning letters to U.S
Weve noticed youre visiting from the United States
[6] Cardiovascular Health Improvements Seen with AOD9604 Metabolic and cardiovascular health are closely linked and its well known that improving the first will also lead to better outcomes in the second area
Moreover, GLP-1RA reduced the risk of MACE by 14% in the overall diabetic population, with an apparent greater effect in patients with established CV disease (16% vs 6% reduction, respectively), although the lack of significant interaction between subgroups does not allow to separate them [12]
If you have cardiovascular disease or significant risk, consult your clinician before beginning long-term use because of the unresolved TMAO issue
After years of research on this compound, l-carnitine is now considered a quasi-vitamin because for most people the human body can produce enough l-carnitine itself